Related Experiment Video
Updated: Jan 15, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Structure-guided approaches to modulate endosomal toll-like receptors TLR7, TLR8 and TLR9: advances, challenges and
Troy Matziol1, Valerij Talagayev2, Günther Weindl1
1University of Bonn, Pharmaceutical Institute, Pharmacology and Toxicology Section, Gerhard-Domagk-Str. 3, 53121 Bonn, Germany.
Abstract:
TLR7, TLR8 and TLR9 are endosomal immune receptors central to antiviral defense, autoimmunity and cancer immunotherapy. Recent structural insights have revealed distinct ligand-binding mechanisms and conformational dynamics, enabling the design of selective small-molecule agonists and antagonists. This review summarizes key advances in TLR7/8/9 biology, pharmacology and structure-guided drug discovery. We highlight clinical progress, delivery strategies and translational challenges including species-specific differences and immune-related toxicities. Novel approaches such as nanoparticle systems and endogenous RNA mimetics promise targeted modulation of TLR activity. Together, these developments emphasize the therapeutic potential of precision TLR modulation in immunologically complex diseases.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Microorganisms in Medicine and Therapeutics
Transduction
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Signal Transduction: Overview
Typically, signal transduction involves three...

